Otsuka Canada Pharmaceutical Revenue and Competitors
Estimated Revenue & Valuation
- Otsuka Canada Pharmaceutical's estimated annual revenue is currently $30.1M per year.
- Otsuka Canada Pharmaceutical's estimated revenue per employee is $201,000
Employee Data
- Otsuka Canada Pharmaceutical has 150 Employees.
- Otsuka Canada Pharmaceutical grew their employee count by 8% last year.
Otsuka Canada Pharmaceutical's People
| Name | Title | Email/Phone |
|---|
Otsuka Canada Pharmaceutical Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $3.2M | 16 | 7% | N/A | N/A |
#2 | $30.2M | 150 | 1% | N/A | N/A |
#3 | $10.7M | 100 | 5% | $39.7M | N/A |
#4 | $104.3M | 519 | 22% | N/A | N/A |
#5 | $47.8M | 238 | N/A | N/A | N/A |
#6 | $15.5M | 77 | 5% | N/A | N/A |
#7 | $395.8M | 1969 | 7% | N/A | N/A |
#8 | $187.3M | 932 | 6% | N/A | N/A |
#9 | $361.6M | 1799 | 6% | N/A | N/A |
#10 | $27.5M | 137 | 0% | N/A | N/A |
What Is Otsuka Canada Pharmaceutical?
Otsuka Canada Pharmaceutical Inc. (OCPI) is an innovative, fast-growing health care company that commercializes Otsuka medicines in Canada, with a focus on commitment to neuroscience, cardio-renal, and oncology. OCPI is dedicated to improving patients' health and the quality of human life. We have recently become aware of fraudulent job offers being made by persons alleging to be acting on behalf of Otsuka. If you are suspicious of a communication received through this site please see the Notice that appears on our company website and refer to the available job postings on our Careers page.
keywords:N/A
N/A
Total Funding
150
Number of Employees
$30.1M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Otsuka Canada Pharmaceutical News
Otsuka Canada Pharmaceutical Inc. (OCPI) today announced that Health Canada has approved Tavneos® (avacopan), an orally administered...
Otsuka Canada Pharmaceutical Inc. announces Health Canada approval of TAVNEOS® (avacopan) for ANCA-Associated Vasculitis.
Otsuka Pharmaceutical is a wholly owned subsidiary of Otsuka Holdings Co., Ltd., based in Tokyo, Japan. The Otsuka group of companies employs...